Source: PR Newswire

Press Release: Trtllc : Softwave Tissue Regeneration Technologies Announces Landmark Trial for Acute Traumatic Spinal Cord Injuries

ATLANTA, Aug. 19, 2020 /PRNewswire/ -- SoftWave® Tissue Regeneration Technologies, a disruptive bio-medical device company, announces the beginning of a trial for "Extracorporeal Shock Wave Therapy in Acute Traumatic Complete and Incomplete Cross - Sectional Lesions." The trial will be...

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
CEO Avatar

CEO

Update CEO

CEO Approval Rating

- -/100

Read more